TransCode Therapeutics Inc (RNAZ)

[Atomic_Insider]

The money laundering founders cash cow milking funnelers criminals of the nasdaq pharmaceuticals. They are experienced fraud artists by profession of the micro Rna nobel scientific community clinical trial hoax, They are very passionate in screwing investors all their careers while they pretend to be victims of their own crimes. They funneled over 150M strait in their pockets with their successfull R/S achievements since inception. Stick around newbie, The federal state penn is their next stop for their hard work and dedication achievements
Executive Committee: TransCode Therapeutics, Inc.
Manager
Positions held
Thomas Fitzgerald
74 year
Chief Administrative Officer 2018-06-30
Chief Executive Officer 2024-01-12
Director of Finance/CFO 2018-06-30
President 2024-01-12
Zdravka Medarova
51 year
Chief Tech/Sci/R&D Officer 2021-09-30
Founder 2015-12-31
Susan Duggan
Chief Operating Officer -
Daniel R. Vlock
73 year
Chief Tech/Sci/R&D Officer 2024-03-27
Composition of the Board of Directors: TransCode Therapeutics, Inc.
Director
Committees
Philippe Calais
66 year
Compensation Committee 2021-02-17
Audit Committee Chair 2021-02-17
Magda Marquet
66 year
Audit Committee 2020-12-31
Executive Committee 2018-05-26
Governance Committee 2021-05-31
Nominating Committee 2021-05-31
Compensation Committee Chair 2021-05-31
Erik Manting
54 year
Audit Committee
Compensation Committee
Governance Committee Chair
Nominating Committee Chair
Thomas Fitzgerald
74 year
Director/Board Member 2018-06-30
Latest Appointments: TransCode Therapeutics, Inc.
TransCode Therapeutics, Inc. Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer
24-03-28
CI
TransCode Reports Additional Restructuring Steps; Chief Executive Michael Dudley to Retire
24-01-12
MT
TransCode Therapeutics, Inc. Announces CEO Changes
24-01-12
CI
TransCode Therapeutics, Inc. Announces Management Changes
24-01-12
CI
TransCode Therapeutics, Inc. Appoints Frank J. Slack to its Advisory Board
22-09-08
CI
TransCode Therapeutics, Inc. Appoints Zdravka Medarova as Chief Technology Officer
21-09-30
CI
TransCode Therapeutics : Names Zdravka Medarova as Chief Technology Officer
21-09-30
MT
More news
Former Officers and Directors: TransCode Therapeutics, Inc.
Insider
Positions held
Robert Dudley
Director/Board Member 2024-01-12
Chief Executive Officer 2024-01-12
Founder 2024-01-12
Public Communications Contact 2024-01-12
President 2024-01-12
Dustan Bonnin
Corporate Officer/Principal 2023-11-30
Qiyong Liu
Chief Tech/Sci/R&D Officer 2023-11-30
Alan Freidman
Investor Relations Contact 2023-11-30
Judy Carmody
Chief Operating Officer -
Anna Moore
Founder -
Oliver Steinbach
Chief Tech/Sci/R&D Officer -